First-In-Human Trial of the Implantable Artificial Bronchus: A Novel Bronchoscopically Delivered Treatment Option for Patients with Severe Emphysema
IAB-1 demonstrated feasibility and a risk profile that improved during the trial by identifying and addressing the need for improved patient selection, implant site selection, implant technique, and delivery system improvements. The IAB may be desirable for emphysema patients who are ineligible for other interventional treatments and wish to avoid surgery.
Authors
- Felix Herth (ORCID: https://orcid.org/0000-0002-7638-2506)
- Dirk‐Jan Slebos (ORCID: https://orcid.org/0000-0001-9555-3422)
- Hugo Goulart de Oliveira (ORCID: https://orcid.org/0000-0003-1471-0890)
Institutions
- Universidade Federal do Rio Grande do Sul (BR)
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Hospital de Clínicas de Porto Alegre (BR)
- Frauenklinik Heidelberg (DE)
Publication Details
- Journal
- Respiration
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1159/000548873
- Primary Topic
- Tracheal and airway disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00